Reduction of Spontaneous Prematurity by Antibiotic Treatment (Josamycin)
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the effectiveness of an antibiotic treatment (Josamycin)
in the case of positive PCR for Ureaplasma spp. and/or Mycoplasma hominis in the second
quarter on the risk of premature birth.